Doreen M. Agnese, MD of The OSU Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute and/or Yale University School of Medicine discusses Surgical and Radiation Treatment Updates to Management of Breast Cancer, Including SABCS Updates
Link To Event –
https://web.cvent.com/event/1e5680ef-4f00-4f94-aae2-4e43c3d17eac/websitePage:645d57e4-75eb-4769-b2c0-f201a0bfc6ce
Link To Dr. Agnese’s Bio –
https://cancer.osu.edu/find-a-doctor/search-physician-directory/doreen-m-agnese
Latest Clinical Trial –
https://clinicaltrials.gov/ct2/show/NCT01901094
I’m a surgical oncologist, clinical geneticist, and researcher who treats breast cancer patients. I specialize in treating high-risk breast cancer patients as a surgeon.
I advise patients as a geneticist on risk assessments based on family background, genetic testing and preventive screening choices, and treatments. My research focuses on all aspects of surgical oncology and cancer genetics, two of the most prominent genes associated with breast cancer risk, particularly breast tumors associated with the inheritable BRCA1 and BRCA2 genes.
I am dedicated, in addition to my clinical practice, to training the next generation of oncologists. I teach young doctors and mentor them, organize programs for extension and continuing education, and train genetic counseling students. In terms of both research and teaching, I have published my work extensively. My writing is written as chapters of books, curriculum, studies, and much more.
From 2017 to 2019, I have been named to several Castle Connolly lists, including “Regional Top Doctors” and “Exceptional Women in Medicine” for 2019, and in 2016, 2017, and 2019, I was ranked in the top 10 percent of physicians in the nation for patient satisfaction. I still serve as a member of the American College of Surgeons (Ohio District #3) Committee on Applicants.